found that base modification could considerably reduce the hepatotoxicity of gapmer ASO, 245 providing insights for developing new gapmer ASOs
Notably, an analysis of hepatic gene expression of MAFLD patients showed that the expression of FMO1 but not FMO3 increases in MAFLD ( Statements Author contributions XL and JH participated in drafting the manuscript
and for some patients who pay out of pocket for the medicine, lower out-of-pocket costs might drive adoption
cut their weekly food and alcohol spending by an average of 36%, saving up to $6,754 and 4,425 annually
Its molecular weight is sequence-dependent, and its chemical stability is considered high when stored under recommended conditions
Throwing away one dose is safer than risking reduced effectiveness during your critical treatment window when your body is building tolerance to the GLP-1 pathway activation